These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 7998343)

  • 21. Binding properties of C-truncated delta opioid receptors.
    Wang CH; Zhou DH; Chen J; Li GE; Pei G; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):337-40. PubMed ID: 10072917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid receptor selectivity of peptide models of beta-endorphin.
    Taylor JW; Kaiser ET
    Int J Pept Protein Res; 1989 Jul; 34(1):75-80. PubMed ID: 2551833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Function of negative charge in the "address domain" of deltorphins.
    Lazarus LH; Salvadori S; Santagada V; Tomatis R; Wilson WE
    J Med Chem; 1991 Apr; 34(4):1350-5. PubMed ID: 1849997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrimination of a novel type of rat brain delta opioid receptors by enkephalin analog containing structurally constrained cyclopropylphenylalanine (inverted delta Phe).
    Chuman Y; Yasunaga T; Costa T; Shimohigashi Y
    Biochem Mol Biol Int; 1997 Sep; 42(6):1227-33. PubMed ID: 9305540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of opioid ligand-receptor interaction models: the structural basis of mu vs delta selectivity.
    Mosberg HI; Fowler CB
    J Pept Res; 2002 Dec; 60(6):329-35. PubMed ID: 12464111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of mu/delta opioid ligands: enkephalin analogues containing 4-anilidopiperidine moiety.
    Lee Y; Petrov R; Kulkarni V; Min BJ; Ma SW; Davis P; Oyarzo J; Vanderah T; Lai J; Porreca F; Vardanyan R; Hruby VJ
    Adv Exp Med Biol; 2009; 611():517-8. PubMed ID: 19400292
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence of a peptide backbone contribution toward selective receptor recognition for leucine enkephalin thioamide analogs.
    Clausen K; Spatola AF; Lemieux C; Schiller PW; Lawesson SO
    Biochem Biophys Res Commun; 1984 Apr; 120(1):305-10. PubMed ID: 6324793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist-antagonist properties of N-allyl-[D-Ala]2-Met-enkephalin.
    Pert CB; Bowie DL; Pert A; Morell JL; Gross E
    Nature; 1977 Sep; 269(5623):73-5. PubMed ID: 197431
    [No Abstract]   [Full Text] [Related]  

  • 31. Rat jejunal permeability and metabolism of mu-selective tetrapeptides in gastrointestinal fluids from humans and rats.
    Krondahl E; Orzechowski A; Ekström G; Lennernäs H
    Pharm Res; 1997 Dec; 14(12):1780-5. PubMed ID: 9453068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic degradation studies of endomorphin-2 and its analogs containing N-methylated amino acids.
    Janecka A; Kruszynski R; Fichna J; Kosson P; Janecki T
    Peptides; 2006 Jan; 27(1):131-5. PubMed ID: 16087275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular dichroism study of the carbohydrate-modified opioid peptides.
    Horvat S; Otvos L; Urge L; Horvat J; Cudić M; Varga-Defterdarović L
    Spectrochim Acta A Mol Biomol Spectrosc; 1999 Sep; 55A(11):2347-52. PubMed ID: 10581740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of modification of the carboxyl group in short D-arginine 2-containing enkephalin analogs on their affinity and selectivity for opiate receptors].
    Inkina NM; Rozental' GF; Bobrova IV; Chipens GI
    Ukr Biokhim Zh (1978); 1990; 62(4):15-20. PubMed ID: 2173185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
    Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A
    Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
    Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K
    Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding selectivity of short [D-Arg2,Leu5]enkephalin analogues to mu- and delta-subclasses of opiate receptors.
    Rosenthal GF; Inkina NM; Abissova NA; Bobrova IV; Chipens GI
    Biomed Sci; 1990 Apr; 1(4):414-6. PubMed ID: 1966782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Receptor selectivity profile of short enkephalin analogs containing D-ornithine at the second position of the molecule].
    Inkina NM; Rozental' GF
    Ukr Biokhim Zh (1978); 1994; 66(2):64-70. PubMed ID: 7998343
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.